Vitamin D for the management of multiple sclerosis (Q24235702)

Europe PubMed Central

title

Vitamin D for the management of multiple sclerosis (English)

0 references

0 references

0 references

0 references

2

0 references

author name string

Vanitha A Jagannath

1

0 references

G V Asokan

3

0 references

Edward W Robak

4

0 references

Liz Whamond

Cochrane Database of Systematic Reviews

5

0 references

publication date

8 December 2010

0 references

published in

0 references

cites work

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Effects of alfacalcidol therapy on serum cytokine levels in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

How to formulate research recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

New clues about vitamin D functions in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Clinical aspects of vitamin D in the management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Vitamin D and autoimmune disease--implications for practice from the multiple sclerosis literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Therapeutic potential of vitamin D for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

UVR, vitamin D and three autoimmune diseases--multiple sclerosis, type 1 diabetes, rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

Long-term therapy with cyclosporin A does not influence serum concentrations of vitamin D metabolites in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

7 January 2021

Prevention of corticosteroid-induced osteoporosis by alfacalcidol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

7 January 2021

Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

7 January 2021

Safety of vitamin D3 in adults with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

7 January 2021

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

7 January 2021

Mortality of multiple sclerosis in Spain: demonstration of a north-South gradient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

7 January 2021

25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

7 January 2021

Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008422.PUB2

7 January 2021

10.1002/14651858.CD008422.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2885226

2885226

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference